Latest News In AI Chips - AI-Powered Shift: Transforming Data Into Business Intelligence
NVIDIA Corporation NVDA | 0.00 |
Treasure Global Inc. has secured a US$15 million contract to develop an AI-powered Social Listening Platform for Creative World Industries, emphasizing the growing demand for AI systems that convert digital data into actionable insights. This platform leverages machine learning and NVIDIA-powered infrastructure to provide real-time sentiment and trend analytics across various sectors. The deployment underscores a trend in the AI chips industry towards enhancing real-time decision intelligence using advanced computing technologies. Such advancements highlight the expanding role of AI in transforming unstructured digital interactions into structured business intelligence, supporting marketing and customer experience decision-making processes across multiple industries.
- NVIDIA (NasdaqGS:NVDA) last closed at $204.87 up 2.2%.
Elsewhere in the market, HANMI Semiconductor (KOSE:A042700) was a standout up 23.5% and closing at ₩359,500. Meanwhile, SJ Semiconductor (SHSE:688820) lagged, down 9.2% to end the day at CN¥156.19.
Best AI Chip Stocks
- Micron Technology (NasdaqGS:MU) settled at $995.87 up 11.7%. This week, the company appointed Dr. Alexis Black Björlin, a seasoned technology executive with extensive AI and semiconductor expertise, to its board of directors.
- Advanced Micro Devices (NasdaqGS:AMD) ended the day at $488.45 up 8%.
- Broadcom (NasdaqGS:AVGO) ended the day at $385.57 up 3.6%. This week, Broadcom announced the AI XPV Platform with Apollo and Blackstone to boost compute capacity for AI labs, alongside initiating debt-financing tender offers.
Turning Ideas Into Actions
- Click here to access our complete index of 120 AI Chip Stocks, which features SG Micro, Infineon Technologies and Hygon Information Technology.
- Looking For Alternative Opportunities? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
